Literature DB >> 32669381

A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.

Laure Boizeau1, Annabelle Servant-Delmas1, Alexandra Ducancelle2,3, Stéphane Chevaliez4, Vincent Thibault5, Syria Laperche6, Pierre Cappy6.   

Abstract

The high genetic variability of hepatitis B virus (HBV) can impair DNA quantification. Here, we investigate a major underquantification of HBV by the cobas TaqMan HBV assay (CTM; Roche). In France, between 2005 and 2017, HBV DNA was detected in 3,102 blood donations by use of the CTM (95% limit of detection [LOD95], 4.8 IU/ml). HBV strains were sequenced in the S region (LOD95, ∼30 IU/ml). Concordant (n = 120) and discordant (n = 45) samples were identified according to the agreement between the plasma viral load (pVL) determined by the CTM and sequencing; all samples were also quantified using the RealTime HBV assay (RTH; Abbott). The viral signature, cloning, and mutagenesis were used to characterize the polymorphism responsible for CTM misquantification. A CTM-RTH discordance (>1 log IU/ml) was found in 14/45 samples that had low pVLs and were successfully genotyped (pVLlow genoS+). PreC/C clones of concordant (C1, C2) and discordant (D1, D2) strains were used to challenge the CTM. Strains D1 and D2 were highly underquantified (42- and 368-fold). In clones, mutating the region corresponding to the CTM reverse primer from a discordant sequence to a concordant sequence restored the levels of quantification to 24% (D1→C1) and 59% (D2→C1) of theoretical levels, while mutating the sequence of a concordant strain to that of a discordant strain led to 78-fold (C1→D1) and 146-fold (C1→D2) decreases in quantification. Moreover, mutating positions 1961 and 1962 was enough to induce a 5-fold underquantification. We conclude that the CTM underestimates pVLs for HBV strains with mutations in the reverse primer target. Specifically, the polymorphism at nucleotides 1961 and 1962 is naturally present in 4.79 and 4.22% of genotype A and D strains, which are highly frequent in Europe, leading to a 5-fold decrease in quantification. Quantification using the new-generation Roche C4800 assay is not affected by this polymorphism.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  diagnosis; hepatitis B virus; plasma viral load; underquantification; viral surveillance

Mesh:

Substances:

Year:  2020        PMID: 32669381      PMCID: PMC7448625          DOI: 10.1128/JCM.00647-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Authors: 
Journal:  J Hepatol       Date:  2017-04-18       Impact factor: 25.083

2.  Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA.

Authors:  Florence Abravanel; Sébastien Lhomme; Pauline Trémeaux; Marion Migueres; Agnès Harter; Catherine Haslé; Patrick Bruel; Laurent Alric; Sophie Métivier; Stéphanie Raymond; Jacques Izopet
Journal:  Diagn Microbiol Infect Dis       Date:  2019-11-16       Impact factor: 2.803

3.  National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France.

Authors:  Annabelle Servant-Delmas; Mélanie Mercier; Marie-Hélène El Ghouzzi; Annie Girault; Françoise Bouchardeau; Josiane Pillonel; Syria Laperche
Journal:  Transfusion       Date:  2010-12       Impact factor: 3.157

Review 4.  Hepatitis B virus genetic diversity and its impact on diagnostic assays.

Authors:  F B Hollinger
Journal:  J Viral Hepat       Date:  2007-11       Impact factor: 3.728

5.  Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0 in serum and plasma matrices.

Authors:  Sebastian Goedel; Matthias Rullkoetter; Sabrina Weisshaar; Carola Mietag; Hermann Leying; Florian Boehl
Journal:  J Clin Virol       Date:  2009-06-16       Impact factor: 3.168

6.  Impact of hepatitis B virus genotypes and surface antigen variants on the performance of HBV real time PCR quantification.

Authors:  Vincent Thibault; Syria Laperche; Sepideh Akhavan; Annabelle Servant-Delmas; Dalila Belkhiri; Anne-Marie Roque-Afonso
Journal:  J Virol Methods       Date:  2009-05-03       Impact factor: 2.014

7.  Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.

Authors:  A Pivert; A Servant-Delmas; F Lunel-Fabiani; H Le Guillou-Guillemette; S Laperche; A Ducancelle
Journal:  J Med Virol       Date:  2014-08-29       Impact factor: 2.327

Review 8.  Genotypes and genetic variability of hepatitis B virus.

Authors:  Anna Kramvis
Journal:  Intervirology       Date:  2014-07-15       Impact factor: 1.763

9.  Molecular characterization of occult hepatitis B virus in genotype E-infected subjects.

Authors:  Astrid Zahn; Chengyao Li; Kwabena Danso; Daniel Candotti; Shirley Owusu-Ofori; Jillian Temple; Jean-Pierre Allain
Journal:  J Gen Virol       Date:  2008-02       Impact factor: 3.891

10.  An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol.

Authors:  Huanting Liu; James H Naismith
Journal:  BMC Biotechnol       Date:  2008-12-04       Impact factor: 2.563

View more
  1 in total

1.  Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing.

Authors:  Xuelian Deng; Xiaohan Guo; Tingting Li; Syria Laperche; Liang Zang; Daniel Candotti
Journal:  Blood Transfus       Date:  2020-12-17       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.